The Effect of cilostazolon Glucose Tolerance and Insulin Resistance in a Rat Model of Non - insulin Dependent Diabetes Mellitus
Sang Ah Chang, Bong Yun Cha, Soon Jib Yoo, Yo Bae Ahn, Ki Ho Song, Je Ho Han, Jong Min Lee, Hyun Sik Son, Kun Ho Yoon, Moo Il Kang, Kwang Woo Lee, Ho Young Son, Sung Ku Kang
Korean J Intern Med. 2001;16(2):87-92. Published online 2001 Jun 1 DOI: https://doi.org/10.3904/kjim.2001.16.2.87
Citations to this article as recorded by 
A Review of Antidiabetic Medicinal Plants as a Novel Source of
Phosphodiesterase Inhibitors: Future Perspective of New Challenges
Against Diabetes Mellitus
Hayat Ouassou, Nour Elhouda Daoudi, Saliha Bouknana, Rhizlan Abdnim, Mohamed Bnouham
Medicinal Chemistry.2024; 20(5): 467. CrossRef
Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia
Adel A. Gomaa, Hanan S.M. Farghaly, Asmaa M. Ahmed, Mohamed A. El-Mokhtar, Fahmy K. Hemida
European Journal of Pharmacology.2022; 921: 174873. CrossRef
Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice
Da Hea Seo, Eugene Shin, Yong-ho Lee, Se-Eun Park, Ki Taek Nam, Jae-woo Kim, Bong-Soo Cha
Biomedicines.2022; 10(8): 1852. CrossRef
Role of Phosphodiesterase in the Biology and Pathology of Diabetes
Agnieszka Kilanowska, Agnieszka Ziółkowska
International Journal of Molecular Sciences.2020; 21(21): 8244. CrossRef
Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes
Sivaram Pillarisetti
Trends in Pharmacological Sciences.2016; 37(3): 207. CrossRef
Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products
Jhih-Syuan Liu, Tsung-Ju Chuang, Jui-Hung Chen, Chien-Hsing Lee, Chang-Hsun Hsieh, Tsung-Kun Lin, Fone-Ching Hsiao, Yi-Jen Hung
Endocrine.2015; 49(3): 703. CrossRef
Cilostazol ameliorates systemic insulin resistance in diabetic db/db mice by suppressing chronic inflammation in adipose tissue via modulation of both adipocyte and macrophage functions
Tsutomu Wada, Yasuhiro Onogi, Yukari Kimura, Tetsuro Nakano, Hiroki Fusanobori, Yoko Ishii, Masakiyo Sasahara, Hiroshi Tsuneki, Toshiyasu Sasaoka
European Journal of Pharmacology.2013; 707(1-3): 120. CrossRef
Phosphodiesterase Inhibitor Improves Renal Tubulointerstitial Hypoxia of the Diabetic Rat Kidney
Hui-Kyoung Sun, Yun Mi Lee, Kum Hyun Han, Han-Seong Kim, Seon-Ho Ahn, Sang-Youb Han
The Korean Journal of Internal Medicine.2012; 27(2): 163. CrossRef
Anti-diabetic effects of 1-methylnicotinamide (MNA) in streptozocin-induced diabetes in rats
Cezary Watała, Piotr Kaźmierczak, Marcin Dobaczewski, Tomasz Przygodzki, Magdalena Bartuś, Magdalena Łomnicka, Ewa M. Słomińska, Zdena Duračkova, Stefan Chłopicki
Pharmacological Reports.2009; 61(1): 86. CrossRef
The Vascular and Biochemical Effects of Cilostazol in Diabetic Patients With Peripheral Arterial Disease
Mark E. O'Donnell, Stephen A. Badger, Muhammad A. Sharif, Ragai R. Makar, Ian S. Young, Bernard Lee, C.V. Soong
Vascular and Endovascular Surgery.2009; 43(2): 132. CrossRef
The Effect of Rosiglitazone on Gluose Metabolism and Insulin Sensitivity in Non Obese Type 2 Diabetic Rat Models
Mi Jin Kim, Eui Jong Chung, Byung Wook Ha, Ji Hoon Kim, Su Min Nam, Mi Young Lee, Jang Hyun Kho, Young Goo Shin, Choon Hee Chung
The Journal of Korean Diabetes Association.2007; 31(4): 319. CrossRef